KLK6 and neoplasm: It has also been shown that KLK6 triggers tumor cells and parenchymal cells in the TME and that the metastasis‐promoting activity of KLK6 may be mediated by its ability to degrade extracellular matrix proteins and E‐cadherin in parallel to the epithelial‐to‐mesenchymal transition (EMT) [33].